Theriva Biologics, Inc. - Common stock (TOVX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common stock
Symbol
TOVX on NYSE
Shares outstanding
9,600,143
Price per share
$0.20
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
437,052
Total reported value
$177,030
% of total 13F portfolios
0%
Share change
+146,040
Value change
+$57,424
Number of holders
18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Theriva Biologics, Inc. - Common stock (TOVX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Jeffrey Matthew Gryga Irrevocable Trust 7.7% $295,684 739,211 Jeffrey Matthew Gryga Irrevocable Trust 24 Oct 2025
Empery Asset Management, LP 5% -50% $201,636 -$179,638 504,091 -47% Empery Asset Management, LP 30 Sep 2025
CVI Investments, Inc. 4.9% $166,595 146,136 CVI Investments, Inc. 31 Dec 2024

As of 30 Sep 2025, 18 institutional investors reported holding 437,052 shares of Theriva Biologics, Inc. - Common stock (TOVX). This represents 4.6% of the company’s total 9,600,143 outstanding shares.

Institutional Holders of Theriva Biologics, Inc. - Common stock (TOVX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 5 $1 +$1 $0.20 1
2025 Q3 437,052 $177,030 +$57,424 $0.41 18
2025 Q2 291,012 $126,275 +$38,329 $0.43 15
2025 Q1 190,680 $209,750 +$165,876 $1.10 9
2024 Q4 34,470 $60,008 -$627,702 $1.75 9
2024 Q3 491,424 $677,871 +$471,524 $1.38 16